Both exposures to toxic metals, as well as deficiencies in essential metals, during pregnancy has been linked to a variety of negative reproductive outcomes. The exact etiologies of such outcomes and the effects of fetal exposure to these metals are largely unknown. Therefore, the ability to assess levels of these elements is critical to determining the underlying causes of such conditions and the effects that both essential and nonessential metals have on fetal development.
Thus, using cell-free fetal RNA from amniotic fluid, we set out to measure the association between amniotic fluid levels of toxic and essential metals and fetal gene expression. We find that arsenic was associated with increased expression of 3 genes known to play roles in both birth-related and reproductive effects. The results highlight the potential for detrimental health effects of prenatal metals exposure and the potential to identify biomarkers of environmental exposure during this critical developmental period.
| INTRODUCTION
Maternal exposure to toxic metals such as inorganic arsenic is associated with low birthweight, spontaneous abortion, stillbirth, and neonatal and infant mortality. 1, 2 In contrast, deficiencies in essential trace metals such as zinc and selenium are associated with pregnancy complications such as miscarriage and preeclampsia. 3 The specific mechanisms by which toxic or essential metals affect pregnancy outcomes is largely unknown; however, metals are known to influence the expression of genes involved in critical biological pathways.
Previous work has shown altered gene expression in newborns exposed to metals such as inorganic arsenic in utero, 4 and such alterations have been used to develop candidate biomarkers of disease, specifically in terms of preterm labor. 5 Therefore, the ability to assess levels of these elements is critical to determining the underlying cause of such conditions and the effects that both toxic and essential metals have on fetal development. Thus, in a highly novel application with clinical relevance to prediction of obstetric complications, we set out to measure the association between amniotic fluid levels of toxic and essential metals and fetal gene expression using cell-free fetal RNA (cffRNA) in a North Carolina cohort.
This pilot study leverages an existing retrospective case-control cohort examining spontaneous preterm birth (sPTB) 6 and was approved by the institutional review board at the University of North Carolina at Chapel Hill. Briefly, eligibility criteria included women who delivered via TB or sPTB (defined as labor without a precipitating factor), with singleton fetuses without structural anomalies, and who Associations between metals exposure and alterations in fetal gene expression were measured using multivariable regression analysis, controlling for maternal age, psychiatric medicines, race, fetal sex, and gestational age at delivery. A Grubbs test was used to identify outliers within the data set. Statistical analyses were performed using Partek Genomics Suite software (version 6.6; Partek Inc, St. Louis, Missouri). Statistical significance was set at a false discovery rate-corrected P-value of ≤.05.
Demographic and exposure characteristics of the study population are summarized in Table 1 . Using inductively coupled plasma mass spectrometry, we examined levels of 3 essential metals, selenium, manganese, and zinc, and 3 toxic metals, arsenic, mercury and lead, Multivariable models displayed that increasing arsenic levels in amniotic fluid were associated with the increased gene expression levels for 3 genes, namely, olfactory receptor, family 4, subfamily S, member 2 (OR4S2); phospholipase C, beta 1 (phosphoinositidespecific) (PLCB1); and progesterone receptor (PGR) (Figure 1 ). The identified genes are known to play roles in birth outcomes, reproductive effects, and in many cases to be responsive to toxic metal exposure. For example, OR4S2 is a G-coupled protein receptor with What's already known about this topic?
• Prenatal toxic metal exposure has been linked to negative reproductive outcomes.
• Effects of in utero exposure to these metals on fetal gene expression is largely unknown.
What does this study add?
• This is the first study to show that in utero arsenic exposure may alter cell-free fetal RNA assessed in amniotic fluid.
• Differential fetal gene expression of OR4S2, PLCB1, and PGR is associated with amniotic fluid arsenic levels.
FIGURE 1 Arsenic-associated upregulation of (A) OR4S2, (B) PLCB1, and (C) PGR with trend line and confidence intervals. Black data points denote ≥37 wk gestation, and gray data points denote <37 wk gestation SMEESTER ET AL.similar domain structure to many neurotransmitter and hormone receptors. In terms of increased health risks, increased copy number variants of OR4S2 has previously been linked to increased risk of sPTB. 7 PLCB1 plays an important role in extracellular signaling, and its upregulation has previously been associated with intrauterine growth restriction. 8 With relevance to hormone signaling in pregnancy,
PGR mediates physiological effects of progesterone. Of the genes, PGR has been previously associated with arsenic exposure where it has been shown that arsenic upregulates PGR protein expression, and increased expression levels are seen in female reproductive disorders. 9 In addition to gene expression profiles, metals measured in amniotic fluid were also tested for their relationship to gestational age at delivery a using multivariable model with statistical significance set at false discovery rate-corrected P ≤ .05. None of the metals tested were associated with gestational age, and only arsenic was associated with differential gene expression. These results were likely impacted by the pilot nature of the study and warrant replication in larger cohorts.
Taken together, these data highlight that metal exposure early in life is associated with altered expression of critical target genes, and support prior work that showed that gene expression can be useful as a biomarker of toxic metal exposure. 4 In summary, while toxic metals are known to cross the placental barrier and have been readily measured in cord blood serum at birth, 10 amniotic fluid provides a unique biological matrix allowing for direct measure of both toxic metals exposure and alteration of fetal gene expression within the fetal compartment. Our findings show fetal exposure to heavy metals can be measured using amniotic fluid and that the NanoString technology can be applied to the measurement of fetal gene expression in this context. While maternal serum was not available for comparison within the present study, we demonstrated that fetal arsenic exposure is associated with differences in targeted gene expression in key pathways that may be related to sPTB.
To the best of our knowledge, our study is among the first to measure the association between toxic metal exposure and fetal gene expression using a custom NanoString panel. Moreover, these results support the Developmental Origins of Health and Disease hypothesis, highlighting the potential for detrimental health effects of prenatal toxic metals exposure and the need to identify biomarkers of environmental exposure during this critical developmental period. Future research will expand upon the current findings to examine the relationships between metals in amniotic fluid and infant health outcomes.
